Hazel has a wealth of experience handling a diverse range of chemical subject-matter which includes pharmaceuticals, industrial chemistry, and consumer chemistry. She particularly focuses on small molecule pharmaceuticals, formulations and new solid forms, as well as dosage regimens including those for combination therapies.
Ben Chapman sits in the Engineering and Tech teams and has experience in oppositions and patent prosecution across a wide range of technologies, including optical engineering, medical devices, and display technology.
Greg’s practice covers a range of technologies in biotechnology, with a particular focus on vaccines, therapeutic antibodies and antisense RNA. His work involves all aspects of patent prosecution at the EPO including attacking and defending patents in post-grant opposition and appeal.
Hugh Goodfellow, Managing Partner at Carpmaels & Ransford, comments:
“Congratulations to Hazel, Ben and Greg on their very well-deserved promotions. It’s great to have watched their progression all the way from joining us as trainees to becoming exceptional patent attorneys and really valued members of their teams.”